Ryohei Ogata

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Ryohei Ogata is an author at Kawasaki Medical School specializing in cyclin-dependent kinase 6 inhibitors, cyclin-dependent kinase 4/6 inhibitors, and oncology.

Publications per year

2019–2020

Publications

Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells

Ryohei Ogata, Emi Kishino, Wataru Saitoh et al. · Breast Cancer · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +17

Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells

Emi Kishino, Ryohei Ogata, Wataru Saitoh et al. · Breast Cancer · 2019 · 19 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2